Assembly Biosciences Inc (ASMB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$36.60+1.30%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ASMB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 72.3 | 28.5 | 7.2 | 0.0 | 6.3 | 79.1 | 16.0 | 14.8 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 63.7 | 64.8 | 55.9 | 48.9 | 70.0 | 68.5 | 106.8 | 85.8 | 72.7 | 44.2 | 33.1 | 18.4 | 10.7 | 15.0 | 19.5 | 25.3 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | 0.0 | — | — | — | — | — | — | — | — |
| Operating Income | (8.8) | (12.1) | (45.4) | (64.6) | (94.1) | (132.7) | (64.8) | (102.7) | (92.7) | (52.2) | (45.3) | (29.7) | (24.0) | (19.6) | (24.9) | (34.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 | 0.1 | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Other Non-Operating Income / Expenses | 8.8 | 6.0 | 5.6 | 3.5 | 1.0 | 0.3 | 2.6 | 4.3 | 3.1 | 0.4 | 0.4 | 1.2 | 0.2 | 0.2 | 0.1 | (0.3) |
| EBT, Incl. Unusual Items | — | (6.1) | (39.8) | (61.2) | (93.1) | (132.4) | (62.2) | (98.4) | (89.7) | (51.9) | (44.9) | — | — | — | — | — |
| Income Tax Expense | — | — | 0.3 | 0.0 | 0.0 | (2.5) | 0.0 | (0.8) | 1.1 | (9.1) | (0.6) | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (0.0) | (6.1) | (40.2) | (61.2) | (93.1) | (129.9) | (62.2) | (97.6) | (90.8) | (42.8) | (44.3) | (28.5) | (23.8) | (19.4) | (24.8) | (34.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.00) | (0.55) | (6.69) | (13.38) | (23.08) | (3.00) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.00) | (0.55) | (6.69) | (13.38) | (23.08) | (3.00) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 18.9 | 11.2 | 6.0 | 4.6 | 4.0 | 43.3 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 18.9 | 11.2 | 6.0 | 4.6 | 4.0 | 43.3 | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (12.0) | (45.3) | (64.2) | (93.6) | (132.2) | (64.1) | (102.2) | — | — | — | — | — | — | — | — |
| EBIT | (8.8) | (12.1) | (45.4) | (64.6) | (94.1) | (132.7) | (64.8) | (102.7) | (92.7) | (52.2) | (45.3) | (29.7) | (24.0) | (19.6) | (24.9) | (34.0) |
| Effective Tax Rate | — | — | — | -0.1% | 0.0% | 1.9% | 0.0% | 0.8% | -1.2% | 17.5% | 1.4% | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.